Хирургическое лечение рака яичников ранних стадий

Обложка

Цитировать

Полный текст

Аннотация

Цель обзора - анализ современных исследований хирургического лечения рака яичников I-II стадий. Основные положения. Обсуждаются отдельные этапы хирургического вмешательства и их значение, влияние объема вмешательства на выживаемость больных и адъювантное лечение, возможность органосохраняющего лечения молодых больных и безопасность лапароскопических вмешательств. Заключение. Показано, что полнота определения стадии раннего рака яичников является независимым прогностическим фактором, определяющим общую и безрецидивную выживаемость больных.

Об авторах

Валентина Михайловна Нечушкина

ФГБУ «НМИЦ онкологии им. Н.Н.Блохина»; ФГБОУ ВО «РНИМУ им. Н.И.Пирогова»

д-р мед. наук, ст. науч. сотр. гинекологического отд-ния НИИ клин. онкологии; проф. каф. онкологии и лучевой терапии ЛФ 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

К Ю Морхов

ФГБУ «НМИЦ онкологии им. Н.Н.Блохина»

Email: k_morkhov@mail.ru
канд. мед. наук, ст. науч. сотр. гинекологического отд-ния НИИ клин. онкологии 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

Зарема Тагировна Абдурагимова

ФГБОУ ВО «МГМСУ им. А.И.Евдокимова»

Email: zarrems@gmail.com
аспирант каф. онкологии ФДПО 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

Виктор Васильевич Кузнецов

ФГБУ «НМИЦ онкологии им. Н.Н.Блохина»

д-р мед. наук, проф., вед. науч. сотр. гинекологического отд-ния НИИ клин. онкологии 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

Владимир Юрьевич Сельчук

ФГБОУ ВО «МГМСУ им. А.И.Евдокимова»

д-р мед. наук, проф.; зав. каф. онкологии ФДПО 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

Вадим Николаевич Дмитриев

ФГАОУ ВО «НИУ БелГУ»; ОГБУЗ «Белгородский онкологический диспансер»

Email: vadd@mail.ru
канд. мед. наук, доцент каф. факультетской хирургии Медицинского института; врач-онколог гинекологического отд-ния 308015, Russian Federation, Belgorod, ul. Pobedy, d. 85

Список литературы

  1. Давыдов М.И., Аксель Е.М. Стандартизованные показатели онкоэпидемиологической ситуации 2015 г. Евразийский онкологический журн. 2017; 5 (2): 261-317.
  2. ESGO guidelines for ovarian cancer surgery. URL: https://guidelines. esgo.org/media/2017/03/ESGO_ovarian_cancer_surgery_brA5_V01-website.pdf
  3. Pecorelli S, Ngan H.Y.S, Hacker N.F. Staging classifications and clinical practice guidelines for gynaecological cancers. URL: https://www.figo.org
  4. Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. J Gynaecol Obstet 2014; 124: 1-5.
  5. Sainz de la Cuesta R, Goff B.A, Fuller A.FJr et al. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms. Obstet Gynecol 1994; 84 (1): 1-7.
  6. Higashi M, Kajiyama H, Shibata K et al. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types. Gynecol Oncol 2011; 123 (3): 474-8.
  7. Paulsen T, Kaern J, Trope C. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. Gynecol Oncol 2011; 122: 83-8.
  8. Тюляндин С.А., Коломиец Л.А., Морхов К.Ю. и др. Практические рекомендации по лекарственному лечению РЯ, первичного рака брюшины и рака маточных труб. Злокачественные опухоли. 2017; 3 (Прил. 2): 135-45.
  9. Young R.C, Decker D.G, Wharton J.T et al. Staging laparotomy in early ovarian cancer. JAMA 1983; 250 (22): 3072-6.
  10. Buchsbaum H.J, Brady M.F, Delgado G et al. Surgical staging of carcinoma of the ovaries. Surg Gynecol Obstet 1989; 169 (3): 226-32.
  11. Arie A.B, McNally L, Kapp D.S, Teng N.N. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II - The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer. Gynecol Oncol 2013; 131 (3): 784-90.
  12. Lee Y, Kim H.S, Chung H.H et al. The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer. Ann Surg Oncol 2014; 21 (8): 2762-6.
  13. Timmers P.J, Zwinderman K, Coens C et al. Lymph node sampling and taking of blind biopsies are important elements of the surgical staging of early ovarian cancer. Int J Gynecol Cancer 2010; 20 (7): 1142-7.
  14. Verleye L, Ottevanger P.B, van der Graaf W et al.; Gynaecological Cancer Group (GCG) of European Organisation for Research and Treatment of Cancer (EORTC). EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer 2009; 45 (4): 517-26.
  15. Ayhan A, Gultekin M, Celik N.Y et al. Occult metastasis in early ovarian cancers: risk factors and associated prognosis. Am J Obstet Gynecol 2007; 196 (1): e1-6.
  16. Fournier M, Stoeckle E, Guyon F et al. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients. Int J Gynecol Cancer 2009; 19 (8): 1307-13.
  17. Morice P, Joulie F, Camatte S et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 2003; 197 (2): 198-205.
  18. Schmeler K.M, Tao X, Frumovitz M et al. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol 2010; 116 (2): 269-73.
  19. Garcia-Soto A.E, Boren T, Wingo S.N et al. Is comprehensive surgical staging needed for thorough evaluation of early-stage ovarian carcinoma? Am J Obstet Gynecol 2012; 206 (3): 242.
  20. Le T, Adolph A, Krepart G.V et al. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 2002; 85 (2): 351-5.
  21. Timmers P.J, Zwinderman A.H, Coens C et al. Understanding the problem of inadequately staging early ovarian cancer. Eur J Cancer 2010; 46 (5): 880-4.
  22. Mayer A.R, Chambers S.K, Graves E et al. Ovarian cancer staging: does it require a gynecologic oncologist? Gynecol Oncol 1992; 47 (2): 223-7.
  23. Signorelli M, Fruscio R, Ceppi L et al. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy. Gynecol Oncol 2014; 132 (2): 312-5.
  24. Trimbos J.B, Vergote I, Bolis G et al. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003; 95 (2): 113-25.
  25. Trimbos B, Timmers P, Pecorelli S et al. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst 2010; 102 (13): 982-7.
  26. Chan J.K, Tian C, Teoh D et al. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2010; 116 (3): 307-11.
  27. Travis L.B, Curtis R.E, Boice J.D et al. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res 1996; 56 (7): 1564-70.
  28. Chi D.S, Abu-Rustum N.R, Sonoda Y et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol 2005; 192 (5): 1614-9.
  29. Zivanovic O, Sonoda Y, Diaz J.P et al. The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecol Oncol 2008; 111 (3): 431-7.
  30. Duska L.R, Chang Y.C, Flynn C.E et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer 1999; 85 (12): 2623-9.
  31. Plaxe S.C, Braly P.S, Freddo J.L et al. Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol 1993; 81 (5): 651-4.
  32. Rodriguez M, Nguyen H.N, Averette H.E et al. National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age. Cancer 1994; 73 (4): 1245-50.
  33. Huber D, Cimorelli V, Usel M et al. How many ovarian cancer patients are eligible for fertility-sparing surgery? Eur J Obstet Gynecol Reprod Biol 2013; 170 (1): 270-4.
  34. Schilder J.M, Thompson A.M, DePriest P.D et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002; 87 (1): 1-7.
  35. Zanetta G, Chiari S, Rota S et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 1997; 104 (9): 1030-5.
  36. Park J.W, Kim D.Y, Suh D.S et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008; 110 (3): 345-53.
  37. Schlaerth A.C, Chi D.S, Poynor E.A et al. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer 2009; 19 (7): 1199-204.
  38. Anchezar J.P, Sardi J, Soderini A. Long-term follow-up results of fertility sparing surgery in patients with epithelial ovarian cancer. J Surg Oncol 2009; 100 (1): 55-8.
  39. Kajiyama H, Shibata K, Suzuki S et al. Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary? Gynecol Oncol 2008; 111 (3): 523-6.
  40. Fruscio R, Corso S, Ceppi L et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol 2013; 24 (1): 138-44.
  41. Kajiyama H, Mizuno M, Shibata K et al. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study. Eur J Obstet Gynecol Reprod Biol 2014; 175: 97-102.
  42. Ditto A, Martinelli F, Lorusso D et al. Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol 2014; 25 (4): 320-7.
  43. Kajiyama H, Shibata K, Mizuno M et al. Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br J Cancer 2011; 105 (9): 1288-94.
  44. Satoh T, Hatae M, Watanabe Y et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 2010; 28 (10): 1727-32.
  45. Wright J.D, Shah M, Mathew L et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer 2009; 115 (18): 4118-26

© ООО "Консилиум Медикум", 2018

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial 4.0 International License.
 


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах